TP53 and cancer: HPV18 E6*I decreases cell proliferation in HPV16 positive cancer cells, while HPV18 E6*I overexpression in p53 null cancer cells does not exhibit this anti-proliferative effect, indicating that this effect could be attributed to protection of p53 by E6*I [110].